Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132836) titled 'A Prospective Study of Pretreatment PET/CT Metabolic Features and the Effectiveness of ^177Lu-PSMA-617 in Advanced Prostate Cancer' on Sept. 18.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Metastatic castration-resistant prostate cancer (mCRPC)
Intervention:
High FDG Metabolic Burden Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: High FDG Metabolic Burden Group:20;Low FDG Metabolic Burden Group:20;
Countries of Recruitment:
China
To know more, visit ...